Beneficial Ownership Report · SCHEDULE 13G/A
Forum Markets, Incorporated
FRMMNASDAQEQUITYCurrent
Beneficial Ownership Report
Company context
We were formed as a clinical stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy. In September 2024, we completed the acquisition of certain source code and intellectual property relating to an online blockchain casino, and moving forward, we plan to focus the majority of our operations on the creation of the online blockchain casino, while looking to monetize certain prior development stage therapeutic product candidates for unmet medical needs.
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Regulation FD Disclosure · Other EventsOct 5, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 21, 2026
- Submission of Matters to a Vote of Security HoldersAug 19, 2026
- 4 filingAug 14, 2026
- 10-Q filingAug 14, 2026
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗